Exosome (Exo), characterized by their superior biocompatibility, biosafety, notable stability, and ability to penetrate physiological barriers, has emerged as promising drug carriers.[14, 15, 16, 17] However, their potential as a platform for selectively activating the STING pathway and alleviating tumor immunosuppression remains underexplored. Here, STING1 is linked to neoplasm.